Press Release

  • For Immediate Release
  • 02/06/2007

SCHWARZ BIOSCIENCES Successfully Implements VISTA for an EDC Study

VISTA web-based site technology assessment service successfully used in a SCHWARZ BIOSCIENCES Electronic Data Capture clinical study.

MEDIA, PA February 6, 2007 - Scientific Software Tools, Inc. (SST), a leader in the area of technology-enabling software and services for clinical trials, and SCHWARZ BIOSCIENCES, the research and development arm of SCHWARZ PHARMA, an innovative multi-national pharmaceutical company, announced today that SCHWARZ BIOSCIENCES has successfully utilized VISTA, a web-based investigative site technology assessment service, in a recent electronic data capture (EDC) clinical study.

PCs at remote investigative sites need to be technologically assessed before any EDC clinical study begins. This ensures that the site meets the hardware and software requirements of the study and is typically carried out via manual assessment surveys, which are slow, expensive, and often inaccurate.

According to Elise Furman, President of SST, “Site investigators and clinical staff often face frustration when conducting technology assessments of clinical study sites. Existing manual assessment methods tend to be time and labor-intensive, tedious and prone to inaccuracies, thus creating delays and problems for site investigators and clinical staff.”

“VISTA is a web-based service designed specifically to solve these problems. It is a quick and easy way for non-technical users in clinical research to carry out the assessment process, leading to significant cost and time savings. Within seconds to minutes, VISTA accurately assesses, captures, and reports on the technology infrastructure of remote sites anywhere around the world. This is a service that is highly beneficial for pharmaceutical sponsors, CROs, and EDC providers.”

Dave Wilson, Associate Director, Clinical Development Applications at SCHWARZ BIOSCIENCES, explains, “through the use of VISTA we were able to qualify the computers at our study sites without putting the site staff or our clinical staff in a position where they had to technically assess computers, a non-trivial task.”

For other information regarding VISTA and how it might help your clinical trial, visit, or contact Scientific Software Tools, Inc., at (610) 891-1640.


One can also experience a free demo of VISTA here.


Headquartered in suburban Philadelphia and founded in 1988 by a M.D. and R.N., Scientific Software Tools, Inc. provides software development services to customers in the pharmaceutical, CRO, manufacturing and healthcare industries.


SCHWARZ BIOSCIENCES represents the research and development arm within the SCHWARZ PHARMA Group. SCHWARZ PHARMA (headquartered in Monheim, Germany) is a research driven pharmaceutical company with approximately 4,400 employees worldwide. The company develops novel medicines in the therapeutic areas of the central nervous system. Furthermore it markets innovative drugs focused to treat cardiovascular and gastro- intestinal diseases. In 2005 the SCHWARZ PHARMA group achieved global sales of nearly 1 billion. The company has a strong international presence with subsidiaries in Europe, USA and Asia. Website.

For more information contact: Elise Furman, Scientific Software Tools, 1023 East Baltimore Pike, Suite 100, Media, PA 19063.

The Right Choice